Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative

Keyphrases

• Synchronous Liver Metastases 100%
• Liver Resection 100%
• Pelvic Exenteration 100%
• Primary Rectal Cancer 100%
• R0 Resection 60%
• Liver 40%
• Oligometastatic 40%
• 5-year Survival 20%
• Metastatic Disease 20%
• Blood Loss 20%
• Timing of Surgery 20%
• Postoperative Outcomes 20%
• Margin Status 20%
• Surgical Outcomes 20%
• Negative Resection Margin 20%
• 30-day Mortality 20%
• Perioperative Morbidity 20%
• Simultaneous Resection 20%
• International Institutions 20%
• Survival Outcomes 20%
• Primary Disease 20%
• Major Postoperative Complications 20%
• R2 Resection 20%
• Advanced Rectal Cancer 20%
• Perioperative Mortality 20%
• Pelvic Dysfunction 20%

Medicine and Dentistry

• Liver Metastasis 100%
• Hepatectomy 100%
• Pelvic Exenteration 100%
• Morbidity 40%
• Bleeding 20%
• Overall Survival 20%
• Metastatic Carcinoma 20%
• Mortality Rate 20%
• Postoperative Complication 20%
• Surgical Margin 20%
• Pelvic Disease 20%